SC directs Glaxo India to deposit Rs 71.21 cr with Drug Prices Equilisation for not selling drugs at govt price

Supreme Court Union of India Vs. Glaxo India Ltd. & ANR. H.L. Dattu, J. 1. The issues that arise for our consideration and decision in this appeal are :- i. Whether the Central Govt. was justified in issuing a demand based on Drug Prices fixed on 02.01.1989, instead of drug prices fixed on 20.11.1986. ii. Whether the Central Government was justified in directing Glaxo India Ltd. (hereinafter referred to as, “Respondent- Company”) to deposit an amount of `71.21 crores in the Drug Prices Equalization Account (in short, “DPEA”). iii. What is the effect...